This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 mg vials of the medication Renflexis. The $7,904.40 firm fixed-price delivery order falls under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate any set-aside requirements, suggesting open competition. The ultimate completion date for this delivery order is December 20, 2024.
Generated 3/20/25, 10:50 AM